American Journal of Epidemiology Advance Access originally published online on June 27, 2006
American Journal of Epidemiology 2006 164(3):197-199; doi:10.1093/aje/kwj205
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Epidemiology Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.
VaccinesVictories and Challenges
1 Task Force for Child Survival and Development, Decatur, GA
2 Emory Vaccine Center, Emory University, Atlanta, GA
3 National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Correspondence to Dr. Alan R. Hinman, Task Force for Child Survival and Development, 750 Commerce Drive, Suite 400, Decatur, GA 30030 (e-mail: ahinman@taskforce.org).
Received for publication April 24, 2006. Accepted for publication May 2, 2006.
| The first 10% of the full text of this article appears below. |
The introduction and widespread use of vaccines has resulted in dramatic reductions in the incidence of many infectious diseases and has succeeded in the global eradication of smallpox. In the United States, immunization coverage levels among children are at all-time highs, and reported vaccine-preventable disease levels are at or near all-time lows, with the exception of pertussis. There have been no cases of paralysis due to indigenously acquired wild poliovirus since 1979, and indigenous transmission of both measles and rubella has been interrupted (1
). This year's issue of Epidemiologic Reviews, the sister publication of this journal, contains 11 articles reviewing a number of issues relating to vaccines and public health.